Mathioudakis Nestoras, Golden Sherita Hill
Division of Endocrinology, Diabetes, and Metabolism, Johns Hopkins University School of Medicine, 1830 E. Monument Street, Suite 333, Baltimore, MD, 21287, USA.
Curr Diab Rep. 2015 Mar;15(3):13. doi: 10.1007/s11892-015-0583-8.
Inpatient glucose management guidelines and consensus statements play an important role in helping to keep hospitalized patients with diabetes and hyperglycemia safe and in optimizing the quality of their glycemic control. In this review article, we compare and contrast seven prominent US guidelines on recommended glycemic outcome measures and processes of care, with the goal of highlighting how variation among them might influence patient safety and quality. The outcome measures of interest include definitions of glucose abnormalities and glycemic targets. The relevant process measures include detection and documentation of diabetes/hyperglycemia, methods of and indications for insulin therapy, management of non-insulin agents, blood glucose monitoring, management of special situations (e.g., parenteral/enteral nutrition, glucocorticoids, surgery, insulin pumps), and appropriate transitions of care. In addition, we address elements of quality improvement, such as glycemic control program infrastructure, glucometrics, insulin safety, and professional education. While most of these guidelines align with respect to outcome measures such as glycemic targets, there is significant heterogeneity among process measures, which we propose might introduce variation or even confusion in clinical practice and possibly affect quality of care. Guideline-related factors, such as rigor of development, clarity, and presentation, may also affect provider trust in and adherence to guidelines. There is a need for high-quality research to address knowledge gaps in optimal glucose management practice approaches in the hospital setting.
住院患者血糖管理指南和共识声明在确保住院糖尿病患者和高血糖患者安全以及优化其血糖控制质量方面发挥着重要作用。在这篇综述文章中,我们比较并对比了美国七项关于推荐血糖结局指标和护理流程的重要指南,目的是突出它们之间的差异可能如何影响患者安全和质量。感兴趣的结局指标包括血糖异常的定义和血糖目标。相关的流程指标包括糖尿病/高血糖的检测与记录、胰岛素治疗的方法和指征、非胰岛素药物的管理、血糖监测、特殊情况(如肠外/肠内营养、糖皮质激素、手术、胰岛素泵)的管理以及适当的护理过渡。此外,我们还讨论了质量改进的要素,如血糖控制项目基础设施、血糖测定、胰岛素安全性和专业教育。虽然这些指南在血糖目标等结局指标方面大多一致,但在流程指标方面存在显著异质性,我们认为这可能会在临床实践中引入差异甚至造成困惑,并可能影响护理质量。与指南相关的因素,如制定的严谨性、清晰度和呈现方式,也可能影响医疗服务提供者对指南的信任和遵循。需要开展高质量研究来填补医院环境中最佳血糖管理实践方法方面的知识空白。